Multiple Chinese HER2 ADCs Close In On Enhertu In Breast Cancer

 
• By Dexter Jie Yan
  
relay race
HER2 ADCs from DualityBio, Hengrui and RemeGen are playing catch-up with Enhertu. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Clinical Trials